Lv2
196 积分 2021-08-03 加入
GSTA1 Conferred Tolerance to Osimertinib and Provided Strategies to Overcome Drug-Tolerant Persister in EGFR-Mutant Lung Adenocarcinoma
2小时前
待确认
Field-effect-informed urine liquid biopsy for bladder cancer
3天前
已完结
Therapeutic targeting of the p300/CBP bromodomain enhances the efficacy of immune checkpoint blockade therapy
15天前
已完结
Radiation Therapy–Induced Mutation Signatures Are Linked to Prognosis
16天前
已关闭
Data from KDM5C-Mediated Recruitment of BRD4 to Chromatin Regulates Enhancer Activation and BET Inhibitor Sensitivity
1个月前
已关闭
The effect of the triazene compound CT913 on ovarian cancer cells in vitro and its synergistic interaction with the PARP-inhibitor olaparib
1个月前
已完结
The effect of the triazene compound CT913 on ovarian cancer cells in vitro and its synergistic interaction with the PARP-inhibitor olaparib
1个月前
已完结
Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor–Targeted Therapy Drives Resistance in Breast Cancer
1个月前
已完结
The Evolving Landscape of Antibody-Based Cancer Therapies: From Monospecific to Multi-Specific and Beyond
2个月前
已完结
Oncogene Mutations: The Shared Antigen Vaccines That Work?
3个月前
已完结
皖公网安备34019202002308
